Time | Treatment choice | Details | Patient response |
---|---|---|---|
SEP 16TH, 2010 | Whole lung lavage | Left lung: 8Â L saline flushed in, 7.5Â L recycled. Right lung: 9Â L saline flushed in, 8.88Â L recycled. | Good response, improvement in symptoms and PA-a maintained throughout 1Â year |
OCT 13TH, 2011 | Whole lung lavage | Left lung: 5.9Â L saline flushed in, 5.68Â L recycled. Right lung: 7Â L saline flushed in, 6.8Â L recycled. | Improved symptoms and PA-a; |
NOV 16TH, 2011 | Whole lung lavage | Left lung: 8.0Â L saline flushed in, 7.7Â L recycled. Right lung: 7Â L saline flushed in, 6.75Â L recycled. | Improved symptoms, PA-a, and pulmonary function; good control of symptoms through 3Â months. |
FEB 2ND, 2012 | Whole lung lavage | Left lung: 8.0Â L saline flushed in, 7.82Â L recycled. Right lung: 8Â L saline flushed in, 7.71Â L recycled. | Symptoms and hypoxia not improved, still required high volume oxygen support; |
FEB 8th-20th, 2012 | 5 sessions of plasmapheresis therapy | Exchange volume: 2.5 L, every 2–3 days during two weeks. | |
JUNE 1ST, 2012 | Whole lung lavage | Left lung: 9.0Â L saline flushed in, 9.33Â L recycled. Right lung: 7.0Â L saline flushed in, 6.98Â L recycled. | Good symptomatic control, with no hypoxia and no further flare of PAP |
JUNE 2nd, 2012 | GM-CSF inhalation | At a dosage of 150 μg, twice daily from day 1 to day 8, with inhalation stopped from day 9 to day 14, every 2 weeks for 3 months; | |
Sep, 2012 | GM-CSF inhalation | At a dosage of 150 μg, once daily from day 1 to day 8, every 2 weeks for 6 month; |